Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/20/2025 | Outperform | William Blair | |
| 10/22/2024 | $32.00 | Outperform | Robert W. Baird |
William Blair initiated coverage of Contineum Therapeutics with a rating of Outperform
Robert W. Baird initiated coverage of Contineum Therapeutics with a rating of Outperform and set a new price target of $32.00
EFFECT - Contineum Therapeutics, Inc. (0001855175) (Filer)
SCHEDULE 13G/A - Contineum Therapeutics, Inc. (0001855175) (Subject)
S-8 - Contineum Therapeutics, Inc. (0001855175) (Filer)